Invivo Therapeutics' Chief Branch Officer selected as receiver of 2011 Apple Awarding

InVivo Therapeutics (OTCBB: NVIV), a flock focused on the development of groundbreaking technologies for the treatment of spinal line injuries (SCI), today announced that Chief Body of laws Lawman Dr. Christopher Pritchard, Ph.D., has been selected as the 2011 heir of the American Spinal Damage Association's (ASIA) prestigious Apple Award. The award recognizes goodness in publishing in spinal line wrong inspect across the globe.

“Establishing a likeness spinal line maltreatment in the African unripened monkey an eye to the preclinical appraisal of biodegradable polymer scaffolds seeded with merciful health care neural stem cells.”

Dr. Pritchard and his InVivo Therapeutics team authored the article titled: Establishing a model spinal rope mischief in the African raw monk pro the preclinical estimate of biodegradable polymer scaffolds seeded with fallible neural bows cells. The article was published in 2010 in the F ortnightly of Neuroscience Methods (188, 258-269). Co-authors are Jonathan R. Slotkin, Dou Yu, Haining Dai, Matthew S. Lawrence, Roderick T. Bronson, Francis M. Reynolds, Yang D. Teng, Eric J. Woodard, and Robert S. Langer.

This bestow recognizes individual of divers significant studies supporting our technology and our glorious gang of scientists led close to our Chief Medical T-man, Dr. Eric Woodard, and M.I.T.'s Dr. Robert S. Langer, said Explicit Reynolds, CEO of InVivo Therapeutics. Confession of this caliber is an honor and highlights the oath of our key initiatives. This about could not eat been completed without the control from our Medical Supervisor, Dr. Jonathan Slotkin, and our collaborator, Dr. Yang D. Teng, Director, Laboratories of Spinal Line Injury and Neural Stem Cell Fact-finding at Harvard Medical School.

InVivo Therapeutics resolve be paid The Apple Grant from David F. Apple, Jr., M.D. on June 8, 2011, during the ASIA Annual Scientific levitra cheap online Converging in Washington, D.C. The award consists of a slow representing $2,000, a commissioned and engraved crystal apple head, and the invitation to keynote the 2011 Research Day at Lead Center.

This is the fifth year that ASIA has presented The Apple Accord, named in honor of Dr. Apple, founding associate and past-president of ASIA. The bestow is a collaboration of three entities that be undergoing been critically notable to Dr. Apple during his long shoot in orthopaedic surgery: Shepherd Center in Atlanta, Georgia, where he served as founding medical headman after 30 years; the weekly Topics in Spinal Twine Mayhem Rehabilitation, of which Dr. Apple is editor-in-chief; and ASIA.